Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025.

Allogene Therapeutics (ALLO) stock Forecast for 2022, 2023, 2024, 2025

The forecast has been updated: September 27, 2021 12:50


Allogene Therapeutics stock price online today

Analyst Target Price

47.73

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Allogene Therapeutics stock today? What is the projected target price level for over the horizon of a year, two, three? How much will be worth in 2021, 2022, 2023?

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Below you can see the results of forecasts for the month, current and future years. Find out target values for stocks, optimistic and pessimistic forecasts.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $47.73 target price for Allogene Therapeutics stock stock.

Today 200 Day Moving Average is the resistance level (27.29 $).

50 Day Moving Average is the resistance level (24.03 $).




Allogene Therapeutics stock monthly Forecast

Date Rate Forecast MIN Rate MAX Rate Volati-
lity, %
29 Sep 21 25.27 23.93 26.55 10.94 %
30 Sep 21 25.03 23.89 25.47 6.60 %
01 Oct 21 25.78 24.97 27.08 8.46 %
02 Oct 21 23.98 23.49 25.10 6.86 %
03 Oct 21 23.37 22.73 24.11 6.05 %
04 Oct 21 23.19 22.28 23.78 6.70 %
05 Oct 21 23.58 22.99 24.37 6.03 %
06 Oct 21 23.96 22.80 25.27 10.81 %
07 Oct 21 23.14 22.38 23.59 5.43 %
08 Oct 21 23.75 23.34 24.42 4.63 %
09 Oct 21 23.97 23.27 25.21 8.37 %
10 Oct 21 24.21 23.51 24.98 6.27 %
11 Oct 21 23.99 23.33 24.47 4.89 %
12 Oct 21 23.92 22.61 24.79 9.63 %
13 Oct 21 25.07 24.58 26.25 6.78 %
14 Oct 21 25.13 24.62 25.78 4.72 %
15 Oct 21 26.27 25.50 27.63 8.37 %
16 Oct 21 28.11 27.64 29.05 5.13 %
17 Oct 21 27.85 27.13 28.96 6.76 %
18 Oct 21 28.42 27.80 29.75 7.01 %
19 Oct 21 28.54 27.38 29.06 6.13 %
20 Oct 21 29.20 28.01 30.26 8.03 %
21 Oct 21 29.40 27.80 30.82 10.88 %
22 Oct 21 28.56 27.72 29.48 6.35 %
23 Oct 21 28.56 27.48 29.80 8.44 %
24 Oct 21 29.62 28.97 30.24 4.36 %
25 Oct 21 27.63 26.78 28.17 5.20 %
26 Oct 21 26.02 25.31 27.35 8.06 %
27 Oct 21 25.98 25.51 26.51 3.92 %
28 Oct 21 24.93 24.55 25.38 3.41 %

ALLO daily forecast for this month


Allogene Therapeutics stock forecast for 29.09.2021.
Estimated Average Forecasted Allogene Therapeutics Price: 25.27 Negative intraday dynamics of the instrument is expected with 9.863% volatility is expected.

Pessimistic forecast: 23.93

Optimistic: 26.55


Allogene Therapeutics stock forecast for 30.09.2021.
Estimated Average Forecasted Allogene Therapeutics Price: 25.03 Negative intraday dynamics of the instrument is expected with 6.192% volatility is expected.

Pessimistic forecast: 23.89

Optimistic: 25.47


Allogene Therapeutics stock forecast for 01.10.2021.
Estimated Average Forecasted Allogene Therapeutics Price: 25.78 Positive intraday dynamics of the instrument is expected with 7.797% volatility is expected.

Pessimistic forecast: 24.97

Optimistic: 27.08


Allogene Therapeutics stock forecast for 02.10.2021.
Estimated Average Forecasted Allogene Therapeutics Price: 23.98 Negative intraday dynamics of the instrument is expected with 6.419% volatility is expected.

Pessimistic forecast: 23.49

Optimistic: 25.10


Allogene Therapeutics stock forecast for 03.10.2021.
Estimated Average Forecasted Allogene Therapeutics Price: 23.37 Negative intraday dynamics of the instrument is expected with 5.701% volatility is expected.

Pessimistic forecast: 22.73

Optimistic: 24.11


ALLO Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Oct 27.82 26.15 29.40 11.07 %
Nov 30.01 28.30 31.96 11.46 %
Dec 30.46 29.31 32.32 9.33 %

Allogene Therapeutics stock forecast for this year


Allogene Therapeutics share price average forecast for Oct 2021 is: 27.8154 The dynamics are positive.
Allogene Therapeutics share price average forecast for Nov 2021 is: 30.0129 The dynamics are positive.
Allogene Therapeutics share price average forecast for Dec 2021 is: 30.4631 The dynamics are positive.


Allogene Therapeutics stock Forecast for 2022

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 29.28 27.11 30.83 12.06 %
Feb 26.41 25.85 28.20 8.33 %
Mar 25.09 23.13 27.09 14.63 %
Apr 27.12 26.44 28.01 5.61 %
May 28.39 27.71 30.32 8.61 %
Jun 28.99 27.16 30.99 12.35 %
Jul 28.67 26.92 30.36 11.33 %
Aug 28.90 26.82 29.62 9.46 %
Sep 28.84 27.66 30.11 8.14 %
Oct 27.89 27.30 28.84 5.32 %
Nov 27.25 26.62 28.04 5.05 %
Dec 26.98 26.09 28.59 8.77 %

Allogene Therapeutics stock Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 28.51 27.06 29.65 8.75 %
Feb 29.25 28.14 30.57 7.94 %
Mar 27.79 25.74 28.49 9.66 %
Apr 26.62 25.16 27.69 9.13 %
May 24.28 23.72 25.18 5.79 %
Jun 23.14 22.19 24.14 8.05 %
Jul 22.93 21.99 24.01 8.40 %
Aug 22.59 22.07 23.20 4.87 %
Sep 23.33 21.58 24.50 11.90 %
Oct 24.85 23.81 25.55 6.81 %
Nov 26.81 25.31 28.42 10.94 %
Dec 26.52 25.62 27.50 6.85 %



Allogene Therapeutics stock Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 27.29 25.38 28.49 10.92 %
Feb 25.51 24.62 27.55 10.65 %
Mar 24.67 23.68 26.32 10.03 %
Apr 25.34 23.64 27.06 12.64 %
May 24.15 22.48 26.05 13.72 %
Jun 24.05 22.13 24.87 11.03 %
Jul 24.39 23.90 25.53 6.40 %
Aug 25.73 24.49 27.61 11.28 %
Sep 27.81 27.06 29.15 7.16 %
Oct 26.78 24.77 27.91 11.23 %
Nov 29.19 27.88 30.89 9.74 %
Dec 28.61 27.67 30.50 9.29 %

Allogene Therapeutics stock Forecast for 2025

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 28.75 27.66 29.79 7.14 %
Feb 29.90 27.93 30.68 8.97 %
Mar 28.47 27.50 30.66 10.31 %
Apr 28.07 25.94 29.44 11.92 %
May 28.83 26.55 30.90 14.09 %
Jun 27.62 26.40 28.44 7.18 %
Jul 28.42 27.28 29.72 8.22 %
Aug 29.36 27.45 30.41 9.75 %
Sep 31.70 29.71 33.61 11.60 %
Oct 34.05 32.62 34.90 6.54 %
Nov 35.14 33.77 36.79 8.21 %
Dec 36.33 35.61 38.59 7.72 %

Allogene Therapeutics overview

Allogene Therapeutics Address

210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

3 648 416 000 $

EBITDA

-134 911 008

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

0

EPS

-1.822

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

78.17

EV To EBITDA

0

52 Week High

44.92

52 Week Low

20.58

50 Day Moving Average

24.03

200 Day Moving Average

27.29

Shares Outstanding

142183000

Shares Float

74537000

Shares Short Prior Month

8353100

Short Ratio

11.07

Percent Insiders

50.23

Percent Institutions

61.47


Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 124.37 (24.09.2021) -0.74 %
AbbVie Inc.
ABBV 107.07 (24.09.2021) -0.27 %
Aeterna Zentaris Inc.
AEZS 0.602564 (24.09.2021) -3.68 %
Allakos Inc.
ALLK 108.17 (24.09.2021) -2.05 %
Allogene Therapeutics, Inc.
ALLO 25.66 (24.09.2021) -7.16 %
Amgen Inc.
AMGN 213.61 (24.09.2021) -0.67 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17 (24.09.2021) -1.73 %
Aurora Cannabis Inc.
ACB 5.95 (24.09.2021) -3.25 %
Becton Dickinson and Company
BDX 253.18 (24.09.2021) -0.25 %
Biogen Inc.
BIIB 291.71 (24.09.2021) -0.51 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 133.38 (24.09.2021) -1.60 %
BioNTech SE
BNTX 333.48 (24.09.2021) -5.53 %
bluebird bio, Inc.
BLUE 18.44 (24.09.2021) -1.18 %
Boston Scientific Corp.
BSX 44.7 (24.09.2021) -0.67 %
Bristol-Myers Squibb Company
BMY 60.23 (24.09.2021) -0.66 %
Canopy Growth Corp.
CGC 13.91 (24.09.2021) -4.46 %
Castle Biosciences, Inc.
CSTL 72.44 (24.09.2021) -3.35 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.73 (24.09.2021) -2.15 %
Eli Lilly and Company
LLY 231.68 (24.09.2021) -0.22 %
Emergent BioSolutions Inc.
EBS 52.39 (24.09.2021) -2.69 %
Exelixis, Inc.
EXEL 20.35 (24.09.2021) -0.73 %
G1 Therapeutics, Inc.
GTHX 15.1 (24.09.2021) -1.44 %
Gilead Sciences, Inc.
GILD 71.19 (24.09.2021) -0.70 %
GlaxoSmithKline plc
GSK 38.39 (24.09.2021) -2.41 %
GoodRx Holdings, Inc.
GDRX 44.13 (24.09.2021) -4.75 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69 (24.09.2021) -1.12 %
Inovio Pharmaceuticals, Inc.
INO 7.76 (24.09.2021) -3.36 %
Johnson & Johnson
JNJ 164.36 (24.09.2021) -0.30 %
Medtronic plc.
MDT 130.02 (24.09.2021) -0.47 %
Merck & Co., Inc.
MRK 73.61 (24.09.2021) 0.77 %
Moderna, Inc.
MRNA 430.14 (24.09.2021) -5.38 %
Novartis AG
NVS 82.93 (24.09.2021) -0.77 %
Novavax, Inc.
NVAX 248.16 (24.09.2021) -3.55 %
ObsEva SA
OBSV 3.15 (24.09.2021) -0.32 %
OrganiGram Holdings Inc.
OGI 2.42 (24.09.2021) -3.20 %
Pfizer Inc.
PFE 43.94 (24.09.2021) -0.57 %
Regeneron Pharmaceuticals, Inc.
REGN 638.9 (24.09.2021) -1.18 %
Sanofi
SNY 47.94 (24.09.2021) -1.60 %
Schrodinger, Inc.
SDGR 57.95 (24.09.2021) -4.23 %
Senseonics Holdings, Inc.
SENS 3.57 (24.09.2021) -4.29 %
Sorrento Therapeutics, Inc.
SRNE 7.83 (24.09.2021) -3.09 %
Stryker Corp.
SYK 276.64 (24.09.2021) 0.17 %
Sundial Growers Inc.
SNDL 0.673 (24.09.2021) -4.06 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (24.09.2021) -1.10 %
Thermo Fisher Scientific Inc.
TMO 609.78 (24.09.2021) 0.25 %
Tilray, Inc.
TLRY 11.67 (24.09.2021) -2.91 %
UnitedHealth Group, Inc.
UNH 407.08 (24.09.2021) -0.23 %
Veeva Systems Inc.
VEEV 299.93 (24.09.2021) 0.41 %
Zomedica Corp.
ZOM 0.5178 (24.09.2021) -2.30 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.46 (24.09.2021) -1.55 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.